New CME Course: LDL-C Reduction in the Patient With Diabetes

Course Launch Announcement: How Low Should We Go and How Should We Get There?

Target audience: The intended audience for the activity is Endocrinologists, Diabetologists, Diabetes Educators, Internists, Clinical Cardiologists, Geriatricians, Nurse Practitioners, Physician Assistants, and other healthcare providers who care for patients with type 2 diabetes and patients with hyperlipidemia.

This activity features 2 prominent experts in cardiovascular disease prevention and diabetes management: Dr. Yehuda Handelsman and Dr. Sergio Fazio. It focuses on LDL-C reduction and includes the latest information on PCSK9 inhibition, especially in patients with diabetes; diabetic dyslipidemia; and guidelines addressing dyslipidemia.

This activity also features a LIVE webinar with Drs. Handelsman and Fazio, who will provide updates to the material they presented and answer learner questions.

This activity, LDL-C Reduction in the Patient with Diabetes: How Low Should We Go and How Should We Get There?offers 0.75 AMA PRA Category 1 Credit(s)™ and is available at: